XML 50 R24.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES
12 Months Ended
Mar. 28, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES

Income tax expense (benefit) for Fiscal Years 2020, 2019, and 2018 consisted of the following:
 
 
Fiscal Year Ended
(in thousands)
 
March 28, 2020
 
March 30, 2019
 
March 31, 2018
Current:
 
 
 
 

 
 

Federal
 
$
15,794

 
$
(1,199
)
 
$
82,523

State
 
2,310

 
2,550

 
4,274

Foreign
 
9,526

 
(1,550
)
 
6,860

Total current provision for (benefit from) income taxes
 
27,630

 
(199
)
 
93,657

Deferred:
 
 
 
 

 
 

Federal
 
(15,606
)
 
(37,577
)
 
9,002

State
 
1,939

 
(4,160
)
 
(1,585
)
Foreign
 
(83,364
)
 
(8,195
)
 
22

Total deferred income tax expense (benefit)
 
(97,031
)
 
(49,932
)
 
7,439

Income tax expense (benefit)
 
$
(69,401
)
 
$
(50,131
)
 
$
101,096



The components of income (loss) before income taxes for Fiscal Years 2020, 2019, and 2018 are as follows:
 
 
Fiscal Year Ended
(in thousands)
 
March 28, 2020
 
March 30, 2019
 
March 31, 2018
United States
 
$
(756,095
)
 
$
(179,387
)
 
$
17,654

Foreign
 
(140,488
)
 
(6,305
)
 
82,573

Income (loss) before income taxes
 
$
(896,583
)
 
$
(185,692
)
 
$
100,227



The following is a reconciliation between statutory federal income taxes and the income tax expense (benefit) for Fiscal Years 2020, 2019, and 2018:
 
 
Fiscal Year Ended
 (in thousands)
 
March 28, 2020
 
March 30, 2019
 
March 31, 2018
Tax expense at statutory rate
 
$
(188,282
)
 
$
(38,995
)
 
$
31,631

Foreign operations taxed at different rates
 
2,497

 
(4,965
)
 
(17,970
)
State taxes, net of federal benefit
 
(14,326
)
 
(1,610
)
 
2,689

Research and development credit
 
(6,498
)
 
(4,288
)
 
(2,023
)
US tax on foreign earnings
 
10,889

 
4,398

 

Impact of Tax Act
 

 
(3,728
)
 
87,790

Goodwill impairment
 
101,604

 

 

Stock based compensation
 
7,369

 
(1,196
)
 
(1,771
)
Internal restructuring related benefit
 
(65,069
)
 

 

Withholding tax
 
2,657

 

 

Deferred tax valuation allowance
 
68,486

 

 

Altera accrual
 
9,467

 

 

Other, net
 
1,805

 
253

 
750

Income tax expense (benefit)
 
$
(69,401
)
 
$
(50,131
)
 
$
101,096



Deferred tax assets and liabilities represent the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes.  

Significant components of the Company's deferred tax assets and liabilities as of March 28, 2020 and March 30, 2019 and are as follows:
(in thousands)
 
March 28, 2020
 
March 30, 2019
Accruals and other reserves
 
$
29,788

 
$
24,167

Deferred compensation
 
277

 
2,980

Net operating loss carry forward
 
11,810

 
16,921

Stock compensation
 
10,867

 
9,484

Interest expense
 
10,676

 
11,550

Tax credits
 
12,437

 
7,072

Engineering costs
 
41,123

 
31,015

Intangible assets
 
94,809

 

Other deferred tax assets
 
3,826

 
635

Valuation allowance(1)
 
(81,436
)
 
(15,787
)
Total deferred tax assets
 
134,177

 
88,037

Deferred gains on sales of properties
 
(1,128
)
 
(1,155
)
Purchased intangibles
 
(55,586
)
 
(92,544
)
Unearned revenue
 
6,521

 
(5,054
)
Unremitted earnings of certain subsidiaries
 
(7,123
)
 
(17,879
)
Fixed asset depreciation
 
818

 
(7,881
)
Right of use assets
 
(5,316
)
 

Total deferred tax liabilities
 
(61,814
)
 
(124,513
)
Net deferred tax assets(2)
 
$
72,363

 
$
(36,476
)

(1) Valuation allowance on federal and state deferred tax assets are net of federal tax impact.
(2) The Company's deferred tax assets for the Fiscal Year ended March 28, 2020 and March 30, 2019, are included as a component of other assets on the consolidated balance sheets.

The Company evaluates its deferred tax assets, including a determination of whether a valuation allowance is necessary, based upon its ability to utilize the assets using a more likely than not analysis.  Deferred tax assets are only recorded to the extent that they are realizable based upon past and future income.  Based on the Company’s results for Fiscal Year 2019 and 2020 together with the Fiscal Year 2021 forecast, the Company recorded a 100% valuation allowance against its US Federal and State deferred tax assets of $71.6 million.

In the period ended March 28, 2020, the Company completed the reorganization of its foreign businesses in conjunction with the Polycom Acquisition in Fiscal Year 2018 and recognized a deferred tax asset relating to the book and tax basis difference of certain intangible assets of $76.5 million

The impact of an uncertain income tax position on income tax expense must be recognized at the largest amount that is more likely than not to be sustained.  An uncertain income tax position will not be recognized unless it has a greater than 50% likelihood of being sustained.  As of March 28, 2020, March 30, 2019, and March 31, 2018, the Company had $152.3 million, $26.5 million, and $12.6 million, respectively, of unrecognized tax benefits.  The increase of uncertain tax positions when compared to the prior year is predominantly due to uncertain tax benefits related to the reorganization of its foreign business and uncertain tax position related to Altera Corp. v. Commissioner IRC Section 482 requiring related-party participants in a cost sharing arrangement to share stock-based compensation costs. The unrecognized tax benefits as of March 28, 2020 would favorably impact the effective tax rate in future periods if recognized.

A reconciliation of the change in the amount of gross unrecognized income tax benefits for the periods is as follows:
(in thousands)
 
March 28, 2020
 
March 30, 2019
 
March 31, 2018
Balance at beginning of period
 
$
26,458

 
$
12,612

 
$
12,854

Increase (decrease) of unrecognized tax benefits related to prior fiscal years
 
11,226

 
254

 
(1,310
)
Increase of unrecognized tax benefits related to business combinations
 
89

 
13,329

 

Increase of unrecognized tax benefits related to current year income statement
 
115,824

 
2,069

 
3,085

Reductions to unrecognized tax benefits related to settlements with taxing authorities
 
(995
)
 

 
(115
)
Reductions to unrecognized tax benefits related to lapse of applicable statute of limitations
 
(295
)
 
(1,806
)
 
(1,902
)
Balance at end of period
 
$
152,307

 
$
26,458

 
$
12,612



The Company's continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. The interest related to unrecognized tax benefits was $4.0 million and $2.0 million as of March 28, 2020 and March 30, 2019, respectively. No penalties have been accrued.

The Company and its subsidiaries are subject to taxation in various foreign and state jurisdictions, including the U.S. The Company is currently being audited by the Internal Revenue Service for Fiscal Year 2017. The Company anticipates a reduction in liabilities for uncertain tax positions that may impact the statement of operations in the next 12 months of approximately $7.3 million relating to the Altera Corp. v. Commissioner IRS assessment and research and development tax credit. All federal tax matters have been concluded for tax years prior to Fiscal Year 2016. Foreign and State income tax matters for material tax jurisdictions have been concluded for tax years prior to Fiscal Year 2013.

The Company believes that an adequate provision has been made for any adjustments that may result from tax examinations; however, the outcome of such examinations cannot be predicted with certainty. If any issues addressed in the tax examinations are resolved in a manner inconsistent with the Company's expectations, the Company could be required to adjust its provision for income tax in the period such resolution occurs.

As of March 28, 2020, after applying Internal Revenue Code (“IRC”) Section 382 limitations, we had $11.8 million of federal and state operating loss carryforwards, with which to offset our future taxable income. The federal and state net operating loss carryforwards will begin to expire in the year 2021.

We experienced an “ownership change” within the meaning of Section 382(g) of the Internal Revenue Code of 1986, as amended, during the second quarter of Fiscal Year 2019. This ownership change has and will continue to subject our net operating loss carryforwards to an annual limitation, which will significantly restrict our ability to use them to offset our taxable income in periods following the ownership change. In general, the annual use limitation equals the aggregate value of our stock at the time of the ownership change multiplied by a specified tax-exempt interest rate.

As of March 28, 2020, the Company had $12.4 million in carryforward tax credits primarily related to California research tax credits which can be carried forward indefinitely.